On-Demand Webinars

  1. Deciphering The Complexity Of Therapeutic Biologics 3/26/2026

    This session breaks down essential analytical approaches that strengthen biologics development, from defining critical quality attributes to supporting comparability and regulatory readiness. 

  2. Unlock The Potential Of GPEx Lightning Accelerate Your HEK Cell Line Development 3/25/2026

    Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on development timelines.

  3. EV Content vs. Function: Using Analytical Tools To Reveal The Connection 3/25/2026

    See how downstream processing affects CD73 expression and function on MSC-EVs through orthogonal analytical methods that connect vesicle content to biological activity and therapeutic potential.

  4. Introducing AgentV: A Scalable Solution For 10X Exosome Yield 3/25/2026

    Understand how a downstream treatment prevents filter fouling during exosome purification, enabling 40-70% particle recovery compared to traditional 5-10% yields while maintaining quality attributes.

  5. A Highly Productive, Chemically Defined Exosome Media System 3/24/2026

    Explore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.

  6. Strategies To Modernize Asset Performance In Manufacturing 3/24/2026

    Learn how to advance from reactive maintenance to predictive, data-driven operations, as well as about APM maturity stages, common transformation challenges, and practical steps to improve reliability.

  7. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

  8. Overcoming Hurdles In Protein Therapy Manufacturing 3/24/2026

    Learn how biopharmaceutical leaders address scalability, quality control, and regulatory challenges when manufacturing protein-based therapies at commercial scale.

  9. Achieving Rapid, High-Titer Expression For Next-Generation Biologics 3/24/2026

    Uncover how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.

  10. Reducing Risk, Increasing Flexibility In Custom Media Manufacturing 3/20/2026

    The session highlights how tailored media solutions, combined with strong scientific understanding and scalable manufacturing practices, can support more efficient, reliable, and future-ready bioprocess development.